DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Star Health and Allied Insurance Company Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 57 min ago·11 Sept 2026, 5:49 am

Star Health & AL INS CO L

Star Health and Allied Insurance Company Limited has announced a virtual investor meet scheduled for September 16, 2026. This event provides an opportunity for the company's management to discuss its business performance, future strategy, and market outlook directly with analysts and investors.

For retail investors, such meetings are a key window to understand the company's direction. They offer insights into management's confidence and can clarify any concerns regarding the company's growth trajectory or operational challenges in the competitive health insurance sector.

Investors should watch for updates on the company's underwriting performance, premium growth, and any strategic initiatives announced during the session. This information will be crucial for assessing the stock's potential in the near future.